X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (821) 821
Book Review (243) 243
Publication (82) 82
Newsletter (29) 29
Magazine Article (13) 13
Conference Proceeding (9) 9
Transcript (2) 2
Book Chapter (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (696) 696
humans (678) 678
male (440) 440
prednisone (440) 440
oncology (431) 431
multiple myeloma (403) 403
aged (385) 385
multiple myeloma - drug therapy (373) 373
hematology (360) 360
female (326) 326
antineoplastic combined chemotherapy protocols - therapeutic use (314) 314
middle aged (313) 313
bortezomib (308) 308
thalidomide (289) 289
melphalan (265) 265
treatment outcome (265) 265
chemotherapy (261) 261
stem-cell transplantation (254) 254
dexamethasone (217) 217
elderly-patients (217) 217
aged, 80 and over (214) 214
thalidomide - administration & dosage (196) 196
adult (184) 184
care and treatment (180) 180
lenalidomide (179) 179
therapy (174) 174
prednisone - administration & dosage (171) 171
cancer (169) 169
multiple myeloma - mortality (167) 167
thalidomide - analogs & derivatives (154) 154
survival (151) 151
antineoplastic combined chemotherapy protocols - adverse effects (141) 141
melphalan - administration & dosage (140) 140
antineoplastic agents - therapeutic use (128) 128
transplantation (127) 127
disease-free survival (126) 126
dexamethasone - administration & dosage (117) 117
prednisone plus thalidomide (117) 117
thalidomide - therapeutic use (114) 114
boronic acids - administration & dosage (111) 111
multiple myeloma - therapy (111) 111
pyrazines - administration & dosage (111) 111
drug therapy (109) 109
corticosteroids (105) 105
trial (105) 105
medicine & public health (102) 102
prostate cancer (101) 101
antineoplastic combined chemotherapy protocols - administration & dosage (100) 100
initial treatment (96) 96
prognosis (95) 95
thalidomide - adverse effects (94) 94
randomized controlled-trial (91) 91
survival analysis (91) 91
survival rate (91) 91
analysis (88) 88
multiple myeloma - diagnosis (87) 87
research (81) 81
multiple myeloma - pathology (80) 80
prostatic neoplasms - drug therapy (80) 80
retrospective studies (80) 80
cyclophosphamide (79) 79
clinical trials (78) 78
prednisone - therapeutic use (78) 78
docetaxel (77) 77
stem cells (75) 75
abridged index medicus (73) 73
hematology, oncology and palliative medicine (72) 72
mitoxantrone plus prednisone (72) 72
cyclophosphamide - administration & dosage (71) 71
phase-iii (69) 69
lenalidomide plus dexamethasone (68) 68
randomized-trial (68) 68
oral melphalan (66) 66
stem cell transplantation (65) 65
antineoplastic agents - administration & dosage (64) 64
follow-up studies (63) 63
phase-ii trial (62) 62
dosage and administration (61) 61
health aspects (61) 61
medicine, general & internal (60) 60
patients (60) 60
transplantation, autologous (60) 60
combination (59) 59
bortezomib-melphalan-prednisone (57) 57
maintenance (56) 56
myeloma (56) 56
recurrence (56) 56
kaplan-meier estimate (52) 52
medical research (52) 52
patient outcomes (52) 52
melphalan - therapeutic use (50) 50
pharmacology & pharmacy (50) 50
randomized controlled trials as topic (50) 50
drug administration schedule (49) 49
diagnosis (48) 48
efficacy (48) 48
hematopoietic stem cell transplantation (48) 48
multiple-myeloma (48) 48
neoplasm staging (48) 48
plus dexamethasone (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (851) 851
German (5) 5
Chinese (3) 3
French (2) 2
Korean (2) 2
Serbian (2) 2
Japanese (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article
Blood, ISSN 0006-4971, 09/2010, Volume 116, Issue 9, pp. 1405 - 1412
Journal Article
Blood, ISSN 0006-4971, 09/2012, Volume 120, Issue 13, pp. 2581 - 2588
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 367, Issue 9513, pp. 825 - 831
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9594, pp. 1209 - 1218
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 22, pp. 3664 - 3670
Journal Article
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 06/2010, Volume 116, Issue 11, pp. 2655 - 2664
BACKGROUND: Targeting the tumor microenvironment and angiogenesis is a novel lymphoma therapeutic strategy. The authors report safety, activity, and angiogenic... 
Angiogenesis | Procarbazine and cyclophosphamide | Etoposide | Metronomic therapy | Prednisone | Recurrent mantle cell lymphoma | Elderly patients | elderly patients | COMBINATION CHEMOTHERAPY REGIMEN | MONOTHERAPY | PROSPECTIVE RANDOMIZED-TRIAL | angiogenesis | PROGRESSION-FREE SURVIVAL | recurrent mantle cell lymphoma | metronomic therapy | STUDY-GROUP GLSG | ENDOTHELIAL PROGENITOR CELLS | PHASE-II TRIAL | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | NON-HODGKINS-LYMPHOMA | etoposide | procarbazine and cyclophosphamide | prednisone | MULTIDRUG THERAPY | Procarbazine - administration & dosage | Recurrence | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Humans | Middle Aged | Neovascularization, Pathologic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Etoposide - administration & dosage | Male | Treatment Outcome | Antibodies, Monoclonal | Thalidomide - administration & dosage | Lymphoma, Mantle-Cell - psychology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Quality of Life | Female | Aged | Care and treatment | Chemotherapy, Combination | Patient outcomes | Mantle cell lymphoma | Dosage and administration | Research | Angiogenesis inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 2/2012, Volume 138, Issue 2, pp. 333 - 339
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2014, Volume 32, Issue 7, pp. 634 - 640
Journal Article
13.